Armada Acquisition Corp. III reported net income of $2,923,560 for the nine months ended September 30, 2026, driven by $5,072,965 of Trust Account interest income. It closed its initial public offering of 24,850,000 units at $10.00 per unit on February 19, 2026, generating gross proceeds of $248,500,000. It has until August 19, 2027 to complete a business combination, and management has determined these conditions raise substantial doubt about its ability to continue as a going concern.
AACIW · Armada Acquisition Corp. III · Documents
$0.15
0.00 (-0.13%)
At close · Nov 17
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 13, 2026
Market Cap
$344.04M
Shares
34.03M
Volume · Nov 17
36.54K
Avg daily vol (3M)
16.53K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Nov 13
Quarterly report
10-Q
Ended Sep 30
Substantial going concern doubt; $248,500,000 IPO closed
Nov 5
Current report
8-K
Events of Oct 31
Brains combination announced at $750.0 million enterprise value
Armada Acquisition Corp. III entered a Business Combination Agreement with Brains Bioceutical Corp. on October 31, 2026, valuing Brains at a $750.0 million enterprise value. The deal includes 14,705,882 earnout shares tied to $12.50 and $15.00 price targets.
Aug 12
Quarterly report
10-Q
FY2026 Q3, ended Jun 30
Quarterly report for FY2026 Q3
AI summary on its way
Net income $1.97M
May 8
Quarterly report
10-Q
FY2026 Q2, ended Mar 31
Quarterly report for FY2026 Q2
AI summary on its way
Net income $423.41K
Mar 20
Annual report
10-K
Ended Dec 31
Annual report for the period ended Dec 31, 2025
AI summary on its way
Mar 16
Feb 25
Feb 23
Current report
8-K
Events of Feb 17
Entered into a material agreement, Unregistered sale of equity, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Other events
AI summary on its way
Feb 18
Feb 12
Feb 9
Feb 5
Jan 28
2025
Oct 22
Registration statement
S-1
Registration statement
Showing 1–14 of 14 documents
Key facts
CIK
2092897
CUSIP
G0R38M101
13F (30d)
41 filings
41 filers
Visit website
Investor relations